This imaging study is able to detect inflammatory changes within the heart muscle caused by sarcoidosis. Perfusion imaging may be used additionally to assess for any sarcoid-related scarring.
The benefits of this scan include:
- Early and Accurate Diagnosis: FDG-PET/CT is highly sensitive in detecting active inflammation in the heart, allowing for the early diagnosis of cardiac sarcoidosis, even when symptoms are subtle or absent.
- Assessing Disease Activity: The scan can measure the metabolic activity of inflamed heart tissue, helping to determine the severity and extent of the disease, which is crucial for effective treatment planning.
- Monitoring Treatment Response: FDG-PET/CT is valuable for monitoring how well a patient is responding to treatment. By assessing changes in inflammation, doctors can adjust therapies to optimize outcomes.
- Guiding Biopsy: If a biopsy is needed, the detailed imaging from the scan can guide the procedure to ensure tissue is taken from the most affected areas, increasing the likelihood of an accurate diagnosis.
- Comprehensive Evaluation: Combining PET with CT allows for a more comprehensive assessment, providing both functional information about inflammation and detailed anatomical images of the heart, which can help in understanding the full impact of the disease.
- Non-Invasive and Safe: The procedure is non-invasive, involving the injection of a radiotracer, and is considered safe, making it a preferred method for ongoing monitoring and management of cardiac sarcoidosis.